Medical Evidence On HCTP Uses | Part 1

Introduction

The body has a way to make sure that each and every system inside are functioning normally and are doing their jobs perfectly. However, there are unwanted pathogens that can enter the body and cause disruption to each of the systems, turning into chronic illnesses over time. A person can feel great one day then feel horrible the next day. When this happens, the body will start to be dysfunctional and in great pain. There are ways to dampen the symptoms of chronic illnesses through the usage of HCTP. In this 2 part series, we will be discussing what HCTP is and how it can treat chronic illness. Part 2 will be continuing to discuss HCTP and its beneficial properties on dampening chronic illnesses effects on the body. By referring patients to qualified and skilled providers that specialized in regenerative cellular therapy, we work with affiliated clinics and distributor organizations, both internationally and nationally with the services that we offer. We find that education is the key to asking valuable questions to our providers. Dr. Jimenez DC provides this information as an educational service only. Disclaimer

Can my insurance cover it? Yes, in case you are uncertain here is the link to all the insurance providers we cover. If you have any questions, please call Dr. Jimenez at 915-850-0900.

What Is HCTP?

HCTP or human cellular treatment products are the body’s own natural raw materials that can help restore cellular integrity. Studies have shown that HCTP can differentiate into any cells in the body and have the ability for self-renewal. Not only that but many affiliated clinics and distribution organizations (both nationally and internationally) have the ability to help individuals that need HCTP treatments to aid some of the chronic symptoms and help boost the body’s natural healing process. This will ensure that the body is healing properly and the individual can continue to live a healthy life.

Medical Evidence Of HCTP

There is evidence that the usage of HCTP can help with many chronic illnesses that the body has encountered. Studies show that HCTP has the ability to rebuild every tissue in the body and has amazing potential for future therapeutic uses in tissue regeneration and repair. Many international therapeutic sessions use HCTP to help alleviate some of the ailments from chronic illnesses that a person is experiencing. Some of the treatments that HCTP can help with include:

• Heart Diseases
• Hepatic Diseases
• Lung Diseases
• Osteo Articular Disorders
• Diabetes
• Autoimmune Diseases

HCTP & Heart Disease

The cardiovascular system is responsible for delivering blood to different parts of the body and making sure that the heart is pumping. When a person has unwanted pathogens that attack the cardiovascular system, whether it is through a lifestyle or they were born with it, it can cause a variety of health problems to the heart. Some of the symptoms of heart disease do vary on what disease a person is experiencing. Affiliated clinics use HCTP as a therapeutic treatment to help repair damaged heart tissues and alleviate heart disease symptoms.

Refractory Angina

For patients with angina, in whom symptoms persist after conventional treatment and who are not candidates for surgery, HCTP therapy has emerged as an instrument with a positive impact on standard therapy. Studies show that refractory angina can cause symptoms of chest pains, shortness of breath, and fatigue in a person. With the usage of HCTP, it can help repair the damaged tissues of the arteries and can reduce mortality. Plus individuals that receive HCTP, have fewer serious adverse effects from refractory angina.

Cardiomyopathy

Many patients with heart failure are exposed to a long process of destruction of the heart muscle, which does not allow restoring heart function, despite optimal medical and surgical management. Research shows that cardiomyopathy is a heart muscle disease that makes it harder for the heart to pump blood into the rest of the body and it can lead to heart failure for an individual. Other studies show that using HCTP treatment can help slow the progression of cardiomyopathy and can help improve a person’s quality of life.

HCTP & Hepatic Disorders

Since the liver is the size of a football, its main purpose is to help the body digest food and get rid of toxic substances that can harm the body. Sadly though through various factors and lifestyles, liver problems can come up randomly and it can cause problems to the individual. Research shows that over time if the liver still has these harmful conditions, it can cause damage and lead to scarring and cause life-threatening conditions to the liver.

Cirrhosis

Research shows that cirrhosis is the late stage of liver disease where healthy liver tissue is replaced with scarred tissue, thus permanently damaging the liver itself. In many patients with cirrhosis and terminal states of liver failure, liver transplantation is not a realistic option. This is due to the shortage of donors, complications related to immunosuppression, complexity, and high costs of surgical intervention. With the application of HCTP, it is currently positioned as a safe option and the best candidate to reverse liver failure. It can help improve the quality and life expectancy of patients since it is the only therapeutic tool that has been shown to be capable of repair.

HCTP & Diabetes

Research shows that diabetes mellitus is a group of diseases that can affect the body’s own blood glucose. Since glucose is what helps the body gets its energy, it is important to have it regulated. However, when there is excess glucose in the body it can lead to diabetes and too much glucose can be in the blood leading to serious health problems. It is accepted that the cause of diabetes mellitus type 1 (DM1) is the self-destruction of pancreatic beta cells, while in type 2 diabetes (DM2) occurs a chronic inflammation of low grade, which causes dysfunction of beta cells and insulin resistance. The remarkable immunomodulatory and anti-inflammatory properties of HCTP have attracted the attention of researchers and clinicians, which explains the numerous clinical trials completed or underway, whose purpose has been to evaluate the safety and effectiveness of HCTP in the treatment of DM1 and DM2.

Conclusion

All in all, HCTP therapies have beneficial properties that can help alleviate chronic symptoms that can cause the body harm. HCTP helps the body regenerate the cellular structure, repair tissue muscles, and organs back to their normal state. By incorporating these treatments along with a healthier lifestyle, the body can have a chance to repair and heal itself much faster and the person can live their life to the fullness and continue on their wellness journey.

References

Biehl, Jesse K, and Brenda Russell. “Introduction to Stem Cell Therapy.” The Journal of Cardiovascular Nursing, U.S. National Library of Medicine, 2009, www.ncbi.nlm.nih.gov/pmc/articles/PMC4104807/.

Grise, Mark A, and Anil Verma. “Treatment of Refractory Angina.” The Ochsner Journal, The Academic Division of Ochsner Clinic Foundation, 2009, www.ncbi.nlm.nih.gov/pmc/articles/PMC3096292/.

Medical Professionals, Cleveland Clinic. “Cirrhosis of the Liver: What Is It, Symptoms, Causes & Stages.” Cleveland Clinic, 1 Nov. 2020, my.clevelandclinic.org/health/diseases/15572-cirrhosis-of-the-liver.

Professionals, Mayo Clinic. “Cardiomyopathy.” Mayo Clinic, Mayo Foundation for Medical Education and Research, 9 Apr. 2021, www.mayoclinic.org/diseases-conditions/cardiomyopathy/symptoms-causes/syc-20370709.

Professionals, Mayo Clinic. “Diabetes.” Mayo Clinic, Mayo Foundation for Medical Education and Research, 30 Oct. 2020, www.mayoclinic.org/diseases-conditions/diabetes/symptoms-causes/syc-20371444.

Professionals, Mayo Clinic. “Liver Disease.” Mayo Clinic, Mayo Foundation for Medical Education and Research, 21 Feb. 2020, www.mayoclinic.org/diseases-conditions/liver-problems/symptoms-causes/syc-20374502.

Zakrzewski, Wojciech, et al. “Stem Cells: Past, Present, and Future.” Stem Cell Research & Therapy, BioMed Central, 26 Feb. 2019, www.ncbi.nlm.nih.gov/pmc/articles/PMC6390367/.

Disclaimer